Merck & Co., Inc. (MRK)

Merck & Co. Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	2,306	365	14,519	13,049	7,067	9,843
Depreciation & Amortization	3,865	3,872	3,909	3,214	3,486	3,310
Share-Based Compensation	676	645	541	479	441	388
Other Operating Activities	7,910	8,124	126	-2,633	-741	-101
Operating Cash Flow	14,757	13,006	19,095	14,109	10,253	13,440
Operating Cash Flow Growth	-5.84%	-31.89%	35.34%	37.61%	-23.71%	23.05%
Capital Expenditures	-3,717	-3,863	-4,388	-4,448	-4,429	-3,369
Acquisitions	-9,560	-10,887	-121	-12,907	-7,606	-4,954
Change in Investments	1,010	703	-483	1,025	2,717	5,420
Other Investing Activities	-833	-36	32	-225	-125	274
Investing Cash Flow	-13,100	-14,083	-4,960	-16,555	-9,443	-2,629
Dividends Paid	-7,542	-7,445	-7,012	-6,610	-6,215	-5,695
Share Issuance / Repurchase	-1,137	-1,221	384	-638	-1,192	-4,419
Debt Issued / Paid	3,434	4,184	-2,251	1,631	5,011	1,248
Other Financing Activities	-325	-328	-240	8,210	-436	5
Financing Cash Flow	-5,570	-4,810	-9,119	2,593	-2,832	-8,861
Exchange Rate Effect	-202	23	-410	-133	253	17
Net Cash Flow	-4,115	-5,864	4,606	14	-1,769	1,967
Free Cash Flow	11,040	9,143	14,707	9,661	5,824	10,071
Free Cash Flow Growth	-1.97%	-37.83%	52.23%	65.88%	-42.17%	21.24%
Free Cash Flow Margin	17.98%	15.21%	24.81%	19.84%	14.03%	25.74%
Free Cash Flow Per Share	4.36	3.60	5.81	3.82	2.30	3.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).